Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53

Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53

US Patent 10876114 · Granted Dec 29, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antisense oligonucleotides for dystrophin exon skipping2025
Oligonucleotide comprising an inosine for treating DMD2023
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrop2022
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2021
Oligonucleotide comprising an inosine for treating DMD2021
Means and methods for counteracting muscle disorders2021
RNA modulating oligonucleotides with improved characteristics for the treatment 2021
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2020
Oligonucleotide comprising an inosine for treating DMD2020
Method for efficient exon (44) skipping in duchenne muscular dystrophy and assoc2019
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2019
RNA modulating oligonucleotides with improved characteristics for the treatment 2019